The study demonstrated the anticancer properties of ECAP to be due to its ability to induce p53 mediated apoptosis in lung cancer cells through activation of oxidative stress and reduction in expression of anti-apoptotic proteins and antioxidant defence proteins. This evidence concerns the gene PROS1 and lung carcinoma.